Cargando…

COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978451/ http://dx.doi.org/10.1007/s40278-021-92563-3

Ejemplares similares

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
por: Risma, Kimberly A., et al.
Publicado: (2021)

The conundrum of COVID-19 mRNA vaccine–induced anaphylaxis
por: Khalid, Muhammad Bilal, et al.
Publicado: (2022)

Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines
por: Kelso, John M.
Publicado: (2021)

Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
por: Moghimi, S. Moein
Publicado: (2021)

Myocarditis rare after COVID-19 mRNA vaccination
Publicado: (2021)

Safety of mRNA COVID-19 vaccines during pregnancy
Publicado: (2022)

Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination
por: Robinson, Lacey B., et al.
Publicado: (2021)

Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines
Publicado: (2021)

mRNA COVID-19 vaccines safe in patients with previous COVID-19 infections
Publicado: (2022)

mRNA-based vs viral vector-based COVID-19 vaccines
Publicado: (2021)

No adverse effects found for prenatal exposure to mRNA COVID-19 vaccine
Publicado: (2022)

Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccines
Publicado: (2022)

Fourth-dose boosters with COVID-19 mRNA vaccines well tolerated
Publicado: (2022)

May polyethylene glycol be the cause of anaphylaxis to mRNA COVID-19 vaccines?()
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2021)

Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation
por: Erdeljic Turk, Viktorija
Publicado: (2021)

Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines
por: Somiya, Masaharu, et al.
Publicado: (2021)

mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation
por: Jaggers, Jordon, et al.
Publicado: (2023)

Cardiac risks higher after COVID-19 infection than mRNA vaccine
Publicado: (2022)

Pfizer-BioNTech COVID-19 vaccine-related risk of anaphylaxis
Publicado: (2021)

Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
Publicado: (2021)

Tolerance of the mRNA COVID-19 vaccines in patients with reported taxane reactions
por: Alenazy, Leila A., et al.
Publicado: (2022)

Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site
por: Myles, Ian A, et al.
Publicado: (2021)

Younger males at greatest risk of myocarditis after mRNA-based COVID-19 vaccination
Publicado: (2022)

Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights
por: Selvaraj, Gurudeeban, et al.
Publicado: (2021)

Universal COVID-19 vaccination cost saving unless anaphylaxis rate high
Publicado: (2021)

COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working Group
por: Kim, Mi-Ae, et al.
Publicado: (2021)

Incidence of immediate allergic reactions to mRNA COVID-19 vaccines in adults with drug allergies and other allergic disorders
por: Marković, Ivan, et al.
Publicado: (2022)

Safety profile of mRNA vaccines during first 6 months of the US COVID-19 vaccination programme reviewed
Publicado: (2022)

Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19
por: Juárez Guerrero, Alba, et al.
Publicado: (2021)

Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
por: Zhou, Zhao-Hua, et al.
Publicado: (2023)

Myocarditis following COVID-19 mRNA vaccination
por: Parmar, Kanak, et al.
Publicado: (2021)

Safety of mRNA COVID-19 vaccinations in patients with allergic diseases
por: Rosada, Tomasz, et al.
Publicado: (2022)

“COVID Arm”: Very delayed large injection site reactions to mRNA COVID-19 vaccines
por: Ramos, Courtney L., et al.
Publicado: (2021)

mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach
por: Banerji, Aleena, et al.
Publicado: (2021)

Allergists Can Safely Evaluate and Revaccinate Individuals With Immediate Allergic Reactions to mRNA COVID-19 Vaccines
por: Greenhawt, Matthew, et al.
Publicado: (2021)

First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing
por: Wolfson, Anna R., et al.
Publicado: (2021)

Risk stratification through extensive allergy work-up in COVID-19-mRNA vaccine allergic reactions
por: Soria, A., et al.
Publicado: (2023)

mRNA 1273: Anaphylaxis: case report
Publicado: (2021)

Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine
por: Yamada, Takayuki
Publicado: (2023)

REVISITING HYPERSENSITIVITY REACTIONS TO THE MRNA COVID-19 VACCINE: TOLERANCE AFTER PREVIOUS HISTORY OF ANAPHYLAXIS
por: AlOtaibi, I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vele5nc1h7pe3djvedcovcv30t